Pharmacophore Modeling and 3D Quantitative Structure-Activity Relationship Analysis of Febrifugine Analogues as Potent Antimalarial Agent.
Pharmacophore modeling and 3D quantitative structure-activity relationship analysis of febrifugine analogues as potent antimalarial agent.
J Adv Pharm Technol Res. 2013 Jan; 4(1): 50-60
Sen D, Chatterjee TK
Febrifugine and its derivatives are effective against Plasmodium falciparum. Using PHASE… Continue reading
Comparison of Responses of Human Melanoma Cell Lines to MEK and BRAF Inhibitors.
Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors.
Front Genet. 2013; 4: 66
Stones CJ, Kim JE, Joseph WR, Leung E, Marshall ES, Finlay GJ, Shelling AN, Baguley BC
The NRAS and BRAF genes… Continue reading
Secondary Bacterial Infections of Buruli Ulcer Lesions Before and After Chemotherapy With Streptomycin and Rifampicin.
Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin.
PLoS Negl Trop Dis. 2013 May; 7(5): e2191
Yeboah-Manu D, Kpeli GS, Ruf MT, Asan-Ampah K, Quenin-Fosu K, Owusu-Mireku E, Paintsil A, Lamptey I,… Continue reading
Viability Reagent, PrestoBlue, in Comparison With Other Available Reagents, Utilized in Cytotoxicity and Antimicrobial Assays.
Viability Reagent, PrestoBlue, in Comparison with Other Available Reagents, Utilized in Cytotoxicity and Antimicrobial Assays.
Int J Microbiol. 2013; 2013: 420601
Lall N, Henley-Smith CJ, De Canha MN, Oosthuizen CB, Berrington D
This study compared different commercially available viability… Continue reading
Application of Liposomes in Drug Development – Focus on Gastroenterological Targets.
Application of liposomes in drug development – focus on gastroenterological targets.
Int J Nanomedicine. 2013; 8: 1325-34
Zhang JX, Wang K, Mao ZF, Fan X, Jiang DL, Chen M, Cui L, Sun K, Dang SC
Over the past decade,… Continue reading
Update on the Treatment of Non-Small-Cell Lung Cancer: Focus on the Cost-Effectiveness of New Agents.
Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents.
Clinicoecon Outcomes Res. 2013; 5: 137-41
Vergnenègre A, Borget I, Chouaid C
The incidence of lung cancer and the cost of drug treatment have… Continue reading
Chlamydophila Pneumoniae Infection and Cardiovascular Disease.
Chlamydophila pneumoniae infection and cardiovascular disease.
N Am J Med Sci. 2013 Mar; 5(3): 169-81
Joshi R, Khandelwal B, Joshi D, Gupta OP
Atherosclerosis is a multifactorial vascular inflammatory process; however, the inciting cause for inflammation remains unclear. Two… Continue reading